Amit Rakhit, M.D., MBA, Promoted to President
Timothy Daly Promoted to Executive Vice President, Finance
NEW YORK, Nov. 01, 2019 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today announced two senior leadership changes to further build the companys capabilities as it approaches topline results from the pivotal Phase 3 NEPTUNE trial for OV101 in Angelman syndrome, expected in mid-2020. Ovids Chief Medical Officer and Head of Research and Development, Amit Rakhit, M.D., MBA, has been promoted to President, in which role he will oversee several functions including commercial, research and development, regulatory, and manufacturing. Amit will retain his title as Chief Medical Officer. In addition, Timothy Daly has been promoted to Executive Vice President, Finance to oversee the companys operations, finance and IT. Tim will retain his title as Treasurer. Both positions will report to Ovids Chairman and Chief Executive Officer, Jeremy Levin, D.Phil., MB, BChir.
2020 is a data-rich year with inflection points across our pipeline, including our pivotal Phase 3 data readout for OV101 in Angelman syndrome, said Dr. Levin. In preparation for these events, Amit and Tim will focus on all relevant capabilities required for our next stage of growth. Amit has been instrumental in driving success across Ovids programs, and under his exceptional leadership he will continue to propel the evolution of these exciting programs. As we have grown, Tims leadership and oversight of our finances and operations have been critical, and as we evolve, he will now lead and integrate additional key functions. I am delighted to announce their promotions today, both of which are very well deserved, and look forward to their continued leadership and guidance.
Amit Rakhit, M.D., MBA, has served as Ovids Chief Medical Officer since March 2016 and Chief Medical Officer and Head of Research and Development since March 2019. Previously, Dr. Rakhit was Senior Vice President, Head of Worldwide Medical at Biogen Inc., from 2014 to 2016 and Vice President, Program Leadership from 2011 to 2014 where he led the Spinraza and dexpramipexole development programs. Earlier, he worked at Bristol-Myers Squibb Company for 10 years, where he held several roles of increasing responsibility in both clinical development (Plavix and Avapro teams) and international medical affairs to support the development, launch execution and life cycle management of several products across the companys portfolio. Dr. Rakhit earned his B.A. in molecular and cell biology from the University of California, Berkeley, M.D. from Tufts University School of Medicine, and dual MBAs from Columbia University and London Business School. Dr. Rakhit completed his fellowship in pediatric cardiology at Harvard Medical School and was previously on staff at Boston Childrens Hospital.
Timothy Daly joined Ovid in September 2015,and has served in positions of increasing responsibility, most recently as Treasurer and Senior Vice President, Finance and Corporate Controller. Prior to Ovid, Mr. Daly was Vice President of Finance and Corporate Controller at Advanced Health Media LLC, a global provider of technology to healthcare professionals. Previously, he served as Vice President, Controller and Chief Accounting Officer at Enzon Pharmaceuticals, Inc., a publicly held pharmaceutical company. Before that, Mr. Daly served in various operational finance roles during his 12-year tenure at ImClone Systems Incorporated, including during the commercial launch of Erbitux, and most recently as Director of Finance. Mr. Daly earned his B.S. in accounting from Rider University.
About Ovid TherapeuticsOvid Therapeutics Inc. is a New York-based biopharmaceutical company using its BoldMedicine approach to develop medicines that transform the lives of patients with rare neurological disorders. Ovid has a broad pipeline of potential first-in-class medicines. The companys most advanced investigational medicine, OV101 (gaboxadol), is currently in clinical development for the treatment of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 (soticlestat) in collaboration with Takeda Pharmaceutical Company Limited for the potential treatment of rare developmental and epileptic encephalopathies (DEE).
For more information on Ovid, please visit http://www.ovidrx.com/.
Forward-Looking Statements This press release includes certain disclosures that contain forward-looking statements, including, without limitation, statements regarding advancing Ovids product candidates, progress, timing, scope and the potential therapeutic benefits based on results of clinical trials for Ovids product candidates; and the anticipated reporting schedule of clinical data regarding Ovids product candidates. You can identify forward-looking statements because they contain words such as will, believes and expects. Forward-looking statements are based on Ovids current expectations and assumptions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that may differ materially from those contemplated by the forward-looking statements, which are neither statements of historical fact nor guarantees or assurances of future performance. Important factors that could cause actual results to differ materially from those in the forward-looking statements include the fact that initial data from clinical trials may not be indicative, and are not guarantees, of the final results of the clinical trials and are subject to the risk that one or more of the clinical outcomes may materially change as patient enrollment continues and/or more patient data become available. Additional risks that could cause actual results to differ materially from those in the forward-looking statements are set forth in Ovids filings with the Securities and Exchange Commission under the caption Risk Factors. Ovid assumes no obligation to update any forward-looking statements contained herein to reflect any change in expectations, even as new information becomes available.
Spinraza is a registered trademark of BiogenPlavix and Avapro are registered trademarks of Sanofi-Aventis Erbitux is a registered trademark of Eli Lilly and Company
Contacts
Investors and Media:Ovid Therapeutics Inc.Investor Relations & Public Relationsirpr@ovidrx.com
Or
Investors: Steve KlassBurns McClellan, Inc.sklass@burnsmc.com (212) 213-0006
Media:Katie Engleman1ABkatie@1abmedia.com(919) 333-7722
Read more:
- Pediatric Cardiology - Pediatrics - University of Rochester Medical Center - April 10th, 2018 [April 10th, 2018]
- Division of Pediatric Cardiology UT Southwestern, Dallas ... - May 7th, 2018 [May 7th, 2018]
- Pediatric and Congenital Cardiology - Massachusetts ... - May 14th, 2018 [May 14th, 2018]
- Pediatric Cardiology Services | Miami | South Florida - June 11th, 2018 [June 11th, 2018]
- RWJMG | Division of Pediatric Cardiology - July 2nd, 2018 [July 2nd, 2018]
- Locations and Directions | Pediatric Cardiology Consultants - July 5th, 2018 [July 5th, 2018]
- Heart Center | MUSC Children's Health | Charleston, SC - July 15th, 2018 [July 15th, 2018]
- Pediatric Cardiologist: Job Description & Career Requirements - July 30th, 2018 [July 30th, 2018]
- Pediatric Cardiology Associates | MEDNAX - August 6th, 2018 [August 6th, 2018]
- Cardiology - Wikipedia - October 15th, 2018 [October 15th, 2018]
- UnityPoint Clinic Pediatric Cardiolgy - November 5th, 2018 [November 5th, 2018]
- Pediatric Cardiology - Pediatrics - University of ... - November 7th, 2018 [November 7th, 2018]
- Pediatric Cardiology | Weill Cornell Medicine - November 7th, 2018 [November 7th, 2018]
- Cardiology | Department of Pediatrics | Columbia ... - November 7th, 2018 [November 7th, 2018]
- Pediatric Cardiology - UofL Physicians - November 18th, 2018 [November 18th, 2018]
- PCA - Pediatric Cardiology Associates - November 30th, 2018 [November 30th, 2018]
- Capital District Pediatric Cardiology Associates - December 9th, 2018 [December 9th, 2018]
- Pediatric Cardiology and Cardiothoracic Surgery (Heart Center) - December 23rd, 2018 [December 23rd, 2018]
- Pediatric Cardiology | Child Cardiology in Louisville ... - December 25th, 2018 [December 25th, 2018]
- Pediatric Cardiology - GHS Childrens - January 28th, 2019 [January 28th, 2019]
- Pediatric Cardiology in New Jersey | Pediatric Heart ... - February 26th, 2019 [February 26th, 2019]
- Overview - Pediatric Cardiology - Mayo Clinic - March 10th, 2019 [March 10th, 2019]
- Pediatric Cardiology | MUSC | Charleston, SC - March 13th, 2019 [March 13th, 2019]
- Pediatric Cardiology Fellowship | Pediatrics at Vanderbilt - March 14th, 2019 [March 14th, 2019]
- Pediatric Cardiology Conferences 2020 | Pediatric Congress ... - March 27th, 2019 [March 27th, 2019]
- Pediatric Cardiology - childrensaterlanger.org - April 4th, 2019 [April 4th, 2019]
- Cardiology | Department of Pediatrics - April 4th, 2019 [April 4th, 2019]
- Pediatric Cardiology - All Volumes & Issues - Springer - April 4th, 2019 [April 4th, 2019]
- Pediatric Cardiology NJ | Pediatric Cardiology New Jersey - April 27th, 2019 [April 27th, 2019]
- Pediatric Cardiology Certification | The American Board of ... - May 12th, 2019 [May 12th, 2019]
- Pediatric Cardiology Center of Oregon - May 12th, 2019 [May 12th, 2019]
- Confirm Rx ICM allies with SharpSense technology and syncs to a smartphone for a superior performance - Cardiac Rhythm News - September 30th, 2019 [September 30th, 2019]
- LI 'garbage man' does 'heart surgery on the side' - Newsday - September 30th, 2019 [September 30th, 2019]
- Five Atlantic Health System Team Members Lauded by NJAHA - Patch.com - September 30th, 2019 [September 30th, 2019]
- Doctors of Distinction: Saluting Westchester's top physicians - Westfair Online - September 30th, 2019 [September 30th, 2019]
- Biology at the Speed of Life - Technology Networks - September 30th, 2019 [September 30th, 2019]
- New Study Discovers the Three-Dimensional Structure of the Genome Replication Machine - Newswise - October 6th, 2019 [October 6th, 2019]
- Universal Pediatric Interventional Cardiology Devices Market Forecast 2019 Catheters, Guidewires, Balloons, Balloon inflation devices, Stents - The... - October 6th, 2019 [October 6th, 2019]
- Pediatric Interventional Cardiology Devices Market Growing Demand and Supply 2019 to 2025 - Weekly Spy - October 6th, 2019 [October 6th, 2019]
- On The Move - Times Union - October 6th, 2019 [October 6th, 2019]
- Pediatric Medical Devices Market Opportunity will Rise to US$ 41000 Mn by 2026 - Space Market Research - October 7th, 2019 [October 7th, 2019]
- Pediatric Interventional Cardiology Market: Industry Development Scenario and Forecast to 2025 - Space Market Research - October 7th, 2019 [October 7th, 2019]
- Global Pediatric Interventional Cardiology Market - Segmented By Type, Application, Technology and Geography - Growth, Trends & Forecast (2019 -... - October 11th, 2019 [October 11th, 2019]
- Want To Know What Equipment Your Pediatricians Use? Here It Is - Healthcare Tech Outlook - October 11th, 2019 [October 11th, 2019]
- Israeli organisation to set up cardiology centre in Rwanda - The New Times - October 11th, 2019 [October 11th, 2019]
- Global Pediatric Interventional Cardiology Market Industry Analysis and Forecast (2018-2026) - Weekly Spy - October 11th, 2019 [October 11th, 2019]
- Media Fall Prey to Researcher Warnings on Men's Drinking Before Conception - NewsBusters - October 11th, 2019 [October 11th, 2019]
- Cleveland Clinics annual Medical Innovation Summit to focus on caring for every life - cleveland.com - October 18th, 2019 [October 18th, 2019]
- Children's hospital to open 4-story addition in November - Newsday - October 18th, 2019 [October 18th, 2019]
- Parent Project Muscular Dystrophy Announces Arkansas Children's Hospital as Their 28th Certified Duchenne Care Center - P&T Community - October 18th, 2019 [October 18th, 2019]
- Top heart surgeon returns to All Childrens, 3 years after being pushed out - Tampa Bay Times - October 18th, 2019 [October 18th, 2019]
- Innovative research on Pediatrics Healthcare Market Outlook to 2019 -2026 Top Companies including GlaxoSmithKline, AstraZeneca, Pfizer, Merck,... - November 1st, 2019 [November 1st, 2019]
- MEDNAX Expands Presence in Florida through Affiliation with Leading Pediatric Plastic Surgery Practice - Business Wire - November 1st, 2019 [November 1st, 2019]
- Apple hires another prominent cardiologist as it makes heart health a big area of focus - CNBC - November 1st, 2019 [November 1st, 2019]
- First Large-Scale Registry to Evaluate Real-World Lipid Management and Effectiveness of PCSK9 Inhibitors Announced - Cath Lab Digest - November 15th, 2019 [November 15th, 2019]
- Ramesh Hospitals Vijayawada sets Guinness World Record for the largest gathering of cardiac surgery patients at one place - Yahoo India News - November 15th, 2019 [November 15th, 2019]
- Market Live: Global Pediatric Interventional Cardiology Devices Market Can Deliver up to High CAGR over the next Few Years - Justnewsindustry - November 21st, 2019 [November 21st, 2019]
- You've got to have heart: Inside UNC Health Care's fight to save a baby with rare transplant - WRAL Tech Wire - November 21st, 2019 [November 21st, 2019]
- Pediatric Interventional Cardiology Devices Market to Record Ascending Growth by 2015 2021 - Downey Magazine - December 3rd, 2019 [December 3rd, 2019]
- Northwest Medical Center Gets Dedicated State-of-the-Art Pediatric ER - Coral Springs Talk - December 3rd, 2019 [December 3rd, 2019]
- New research reveals how antiretroviral drugs may damage the hearts of infants exposed to HIV but uninfected - UB News Center - December 3rd, 2019 [December 3rd, 2019]
- FAQ: An Update on the St. Christopher's Hospital Acquisition - DrexelNow - Drexel Now - December 16th, 2019 [December 16th, 2019]
- Which Of The Top AI Events Is Best Suited For Your Profession? - Forbes - December 16th, 2019 [December 16th, 2019]
- Physician specialties with the highest salaries and the biggest pay increases in 2019 - FierceHealthcare - December 16th, 2019 [December 16th, 2019]
- State-by-state breakdown of the 183 new ASCs opened or announced in 2019 - Becker's ASC Review - January 2nd, 2020 [January 2nd, 2020]
- The news that impacted our communities in 2019 | New Today - Uniontown Herald Standard - January 2nd, 2020 [January 2nd, 2020]
- Father and son both healthy after heart defects at birth - KFSN-TV - January 2nd, 2020 [January 2nd, 2020]
- YOUR HEALTH: He got his dads heart. That wasnt necessarily a good thing - WQAD Moline - January 2nd, 2020 [January 2nd, 2020]
- MEDNAX (NYSE:MD) Rating Lowered to Neutral at Citigroup - Riverton Roll - January 3rd, 2020 [January 3rd, 2020]
- MEDNAX (NYSE:MD) Downgraded to Neutral at Citigroup - Riverton Roll - January 10th, 2020 [January 10th, 2020]
- January Is Thyroid Awareness Month - Newswise - January 10th, 2020 [January 10th, 2020]
- The new year rings in 110 new Drexel Med employees - Drexel University The Triangle Online - January 10th, 2020 [January 10th, 2020]
- Could 2020 be the year of women in cardiology? - Cardiovascular Business - January 10th, 2020 [January 10th, 2020]
- New product developments and trends of Pediatric Interventional Cardiology Market during 2019-2025 - Fusion Science Academy - January 18th, 2020 [January 18th, 2020]
- MEDNAX (NYSE:MD) Lowered to Neutral at Citigroup - Riverton Roll - January 18th, 2020 [January 18th, 2020]
- Major Heart Organizations Now Led by Women - Medscape - January 18th, 2020 [January 18th, 2020]
- Cleveland Clinic Names New Chair of Hillcrest Hospitals Board of Trustees - Health Essentials from Cleveland Clinic - January 18th, 2020 [January 18th, 2020]
- MEDNAX Inc to Post Q4 2019 Earnings of $0.85 Per Share, Jefferies Financial Group Forecasts (NYSE:MD) - Riverton Roll - February 1st, 2020 [February 1st, 2020]
- Lower Stress, Stay Optimistic, and Avoid Heart Attacks- Mount Sinai Health System - Yahoo Finance - February 1st, 2020 [February 1st, 2020]
- Lower Stress, Stay Optimistic, and Avoid Heart Attacks - Cath Lab Digest - February 1st, 2020 [February 1st, 2020]